RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bioporto A/S Stock

Bioporto A/S Net Income 2024

Bioporto A/S Net Income

-43.4 M DKK

Ticker

BIOPOR.CO

ISIN

DK0011048619

WKN

893191

In 2024, Bioporto A/S's profit amounted to -43.4 M DKK, a -22.96% increase from the -56.33 M DKK profit recorded in the previous year.

The Bioporto A/S Net Income history

YEARNET INCOME (undefined DKK)
2025e-98,642.17
2024e-43,395.36
2023-56,328
2022-75,923
2021-57,113
2020-61,562
2019-69,642
2018-38,048
2017-32,243
2016-22,800
2015-10,732
2014-12,926
2013-20,620
2012-14,700
2011-14,840
2010-14,210
2009-15,950
2008-14,740
2007-14,260
2006-15,730
2005-1,700
2004110

Bioporto A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bioporto A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bioporto A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bioporto A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bioporto A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bioporto A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bioporto A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bioporto A/S’s growth potential.

Bioporto A/S Revenue, EBIT and net profit per share

DateBioporto A/S RevenueBioporto A/S EBITBioporto A/S Net Income
2025e52.77 M undefined-60.55 M undefined-98.64 M undefined
2024e40.36 M undefined-41.41 M undefined-43.4 M undefined
202330.96 M undefined-60.16 M undefined-56.33 M undefined
202228.97 M undefined-78.94 M undefined-75.92 M undefined
202124.25 M undefined-65.26 M undefined-57.11 M undefined
202023.2 M undefined-63.59 M undefined-61.56 M undefined
201926.62 M undefined-74.3 M undefined-69.64 M undefined
201826.02 M undefined-41.78 M undefined-38.05 M undefined
201725.16 M undefined-36.49 M undefined-32.24 M undefined
201620.72 M undefined-25.05 M undefined-22.8 M undefined
201520.38 M undefined-12.76 M undefined-10.73 M undefined
201418.71 M undefined-15.26 M undefined-12.93 M undefined
201316.63 M undefined-19.8 M undefined-20.62 M undefined
201217.86 M undefined-13.87 M undefined-14.7 M undefined
201118.58 M undefined-12.86 M undefined-14.84 M undefined
201013.8 M undefined-13.41 M undefined-14.21 M undefined
200911.01 M undefined-16.02 M undefined-15.95 M undefined
20089.88 M undefined-15.48 M undefined-14.74 M undefined
20078.34 M undefined-14.05 M undefined-14.26 M undefined
20065.55 M undefined-14.66 M undefined-15.73 M undefined
20054.36 M undefined140,000 undefined-1.7 M undefined
20042.11 M undefined730,000 undefined110,000 undefined

Bioporto A/S stock margins

The Bioporto A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioporto A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioporto A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bioporto A/S's sales revenue. A higher gross margin percentage indicates that the Bioporto A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bioporto A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bioporto A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bioporto A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bioporto A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bioporto A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bioporto A/S Margin History

Bioporto A/S Gross marginBioporto A/S Profit marginBioporto A/S EBIT marginBioporto A/S Profit margin
2025e65.19 %-114.74 %-186.92 %
2024e65.19 %-102.6 %-107.52 %
202365.19 %-194.34 %-181.95 %
202265.73 %-272.51 %-262.08 %
202162.01 %-269.05 %-235.48 %
202057.49 %-274.05 %-265.31 %
201965.09 %-279.09 %-261.6 %
201868.55 %-160.6 %-146.25 %
201772.54 %-145.08 %-128.18 %
201675.74 %-120.88 %-110.04 %
201575.95 %-62.6 %-52.65 %
201470.55 %-81.56 %-69.1 %
201354.36 %-119.06 %-123.99 %
201261.93 %-77.66 %-82.31 %
20119.31 %-69.21 %-79.87 %
20101.45 %-97.17 %-102.97 %
2009-15.53 %-145.5 %-144.87 %
2008-27.53 %-156.68 %-149.19 %
2007-45.08 %-168.47 %-170.98 %
2006-85.59 %-264.14 %-283.42 %
2005-16.51 %3.21 %-38.99 %
2004-13.27 %34.6 %5.21 %

Bioporto A/S Aktienanalyse

What does Bioporto A/S do?

Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Bioporto A/S's Profit Margins

The profit margins of Bioporto A/S represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Bioporto A/S's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Bioporto A/S's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Bioporto A/S's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Bioporto A/S’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Bioporto A/S stock

How much profit has Bioporto A/S made this year?

Bioporto A/S has made -43.4 M DKK this year.

How has the profit developed compared to last year?

The profit has increased by -22.96% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Bioporto A/S publish its earnings?

Bioporto A/S publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Bioporto A/S?

The profits of Bioporto A/S are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Bioporto A/S?

You can learn more about the earnings of Bioporto A/S by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Bioporto A/S pay?

Over the past 12 months, Bioporto A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioporto A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bioporto A/S?

The current dividend yield of Bioporto A/S is .

When does Bioporto A/S pay dividends?

Bioporto A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bioporto A/S?

Bioporto A/S paid dividends every year for the past 0 years.

What is the dividend of Bioporto A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bioporto A/S located?

Bioporto A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bioporto A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bioporto A/S from 10/7/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 10/7/2024.

When did Bioporto A/S pay the last dividend?

The last dividend was paid out on 10/7/2024.

What was the dividend of Bioporto A/S in the year 2023?

In the year 2023, Bioporto A/S distributed 0 DKK as dividends.

In which currency does Bioporto A/S pay out the dividend?

The dividends of Bioporto A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bioporto A/S

Our stock analysis for Bioporto A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioporto A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.